These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1095309

  • 41. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 42. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH, Schmid R, Spona J.
    Wien Klin Wochenschr; 1981 Oct 16; 93(19):601-4. PubMed ID: 6798765
    [Abstract] [Full Text] [Related]

  • 43. Conception control by vaginal administration of pills containing ethinyl estradiol and dl-norgestrel.
    Coutinho EM, da Silva AR, Carreira C, Rodrigues V, Gonçalves MT.
    Fertil Steril; 1984 Sep 16; 42(3):478-81. PubMed ID: 6381103
    [Abstract] [Full Text] [Related]

  • 44. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies.
    Woutersz TB.
    J Reprod Med; 1975 Sep 16; 15(3):87-92. PubMed ID: 1214254
    [Abstract] [Full Text] [Related]

  • 45. Clinical evaluation of two biphasic and one triphasic norgestrel/ethinyl estradiol regimens.
    Larrañaga A, Sartoretto JN, Winterhalter M, Navas Filho F.
    Int J Fertil; 1978 Sep 16; 23(3):193-9. PubMed ID: 40893
    [Abstract] [Full Text] [Related]

  • 46. Observations with anteovin "step-up" contraceptive tablet in young women.
    Takács G, Hámori M.
    Ther Hung; 1986 Sep 16; 34(3):150-4. PubMed ID: 3441877
    [No Abstract] [Full Text] [Related]

  • 47. A randomized, double-blind study of six combined oral contraceptives.
    Contraception; 1982 Mar 16; 25(3):231-41. PubMed ID: 6804161
    [Abstract] [Full Text] [Related]

  • 48. Clinical studies with a low dose estrogen-progestogen combination.
    Sartoretto JN, Ortega-Recio JC, Moraes R, Filho FN.
    Contraception; 1977 May 16; 15(5):563-70. PubMed ID: 880827
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS, Ayerst RI, Harris JW, Stone RA, Anderson AE, Jones TL, Curtis MK.
    Contraception; 1986 Nov 16; 34(5):435-42. PubMed ID: 3102161
    [Abstract] [Full Text] [Related]

  • 50. The 150/30 formulation. Experience in the United Kingdom.
    Guillebaud J.
    J Reprod Med; 1983 Jan 16; 28(1 Suppl):66-70. PubMed ID: 6403702
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
    Endrikat J, Müller U, Düsterberg B.
    Contraception; 1997 Mar 16; 55(3):131-7. PubMed ID: 9115000
    [Abstract] [Full Text] [Related]

  • 53. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H.
    Acta Obstet Gynecol Scand; 1988 Mar 16; 67(2):171-4. PubMed ID: 2972160
    [Abstract] [Full Text] [Related]

  • 54. Clinical experience with a low dose oral contraceptive containing norethisterone and ethinyl oestradiol.
    Morigi EM, Pasquale SA.
    Curr Med Res Opin; 1978 Mar 16; 5(8):655-62. PubMed ID: 710178
    [Abstract] [Full Text] [Related]

  • 55. Rationale for new oral contraceptive dosing.
    Williams JK.
    Int J Fertil Womens Med; 2004 Mar 16; 49(1):30-5. PubMed ID: 15038507
    [Abstract] [Full Text] [Related]

  • 56. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III-Menstrual patterns. An international comparative trial.
    Sivin I, Mishell DR, Victor A, Diaz S, Alvarez-Sanchez F, Nielsen NC, Akinla O, Pyorala T, Coutinho E, Faundes A, Roy S, Brenner PF, Ahren T, Pavez M, Brache V, Giwa-Osagie OF, Fasan MO, Zausner-Guelman B, Darze E, Gama daSilva JC, Diaz J, Jackanicz TM, Stern J, Nash HA.
    Contraception; 1981 Oct 16; 24(4):377-92. PubMed ID: 6797783
    [Abstract] [Full Text] [Related]

  • 57. [Extended clinical studies on a new biphasic preparation].
    Lachnit U.
    Ther Ggw; 1974 Sep 16; 113(9):1486-505. PubMed ID: 4612855
    [Abstract] [Full Text] [Related]

  • 58. Clinical experience with a triphasic oral contraceptive.
    Ulstein M, Svendsen E, Steier A, Bratt H, Fylling P, Lie S, Schiefloe A, Aaserud J.
    Acta Obstet Gynecol Scand; 1984 Sep 16; 63(3):233-6. PubMed ID: 6428157
    [Abstract] [Full Text] [Related]

  • 59. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 60. [Use of Ovidon, Rigevidon and Postinor for contraception].
    Kulakov VI, Barinov AM, Prilepskaia VN.
    Akush Ginekol (Mosk); 1983 Nov 15; (11):22-4. PubMed ID: 6666791
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.